Andrew Chaffkin

Andrew Chaffkin

Senior Quality Assurance Manager @ Bristol Myers Squibb

About Andrew Chaffkin

Andrew Chaffkin is the Senior Quality Assurance Manager at Bristol Myers Squibb with over 13 years of experience in the pharmaceutical and biotechnology industries.

Current Role at Bristol Myers Squibb

Andrew Chaffkin currently serves as a Senior Quality Assurance Manager at Bristol Myers Squibb. In this role, he is responsible for overseeing quality assurance processes, ensuring compliance with industry standards, and maintaining high-quality outcomes in pharmaceutical products. His position signifies a high level of responsibility and trust within the organization, backed by his extensive experience in both manufacturing and quality assurance.

Previous Roles at Bristol Myers Squibb

Before his current role, Andrew Chaffkin has held significant positions at Bristol Myers Squibb. From 2020 to 2022, he worked as a Quality Assurance Supervisor in Bothell, Washington. Prior to that, he was a Manufacturing Supervisor for five months in 2019. These positions demonstrate his versatility within the company, transitioning from manufacturing to quality assurance, reflecting his broad skill set and adaptability in the pharmaceutical and biotechnology sectors.

Experience at Juno Therapeutics, Inc.

Andrew Chaffkin worked at Juno Therapeutics, Inc. as a Manufacturing Supervisor from 2018 to 2019. Based in Bothell, Washington, a key location for biotechnology firms, he gained valuable experience overseeing manufacturing processes. This role further solidified his expertise in the biotechnology industry and prepared him for subsequent positions that require a deep understanding of manufacturing operations.

Tenure at Alexion Pharmaceuticals

Andrew Chaffkin’s career includes a seven-year tenure at Alexion Pharmaceuticals, where he served as a Manufacturing Associate from 2010 to 2017. This extended period in a manufacturing role provided him with a solid foundation in pharmaceutical production processes, contributing to his proficiency in the industry. His long-term commitment to Alexion Pharmaceuticals indicates a strong work ethic and dedication to his professional development.

Educational Background in Chemical and Biomolecular Engineering

Andrew Chaffkin obtained his Bachelor of Science in Engineering (BSE) in Chemical and Biomolecular Engineering from the University of Pennsylvania, where he studied from 2006 to 2010. This educational background provided him with a robust understanding of engineering principles, specifically tailored to the biotechnological and pharmaceutical fields. His academic credentials support his extensive practical experience, making him well-rounded in his professional capabilities.

People similar to Andrew Chaffkin